Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will develop and experimentally test the efficiency of a neurofeedback training protocol vs. varenicline use for smoking cessation.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aristotle University Of Thessaloniki
• Collaborators: AAI Scientific Cultural Services Ltd (AAISCS); NATIONAL ASSOCIATION OF GENERAL PRACTITIONERS IN BULGARIA
• Treatments: Varenicline

Criteria

Inclusion Criteria:

• Being continuous tobacco smokers (>10 cigarettes per day) for at least 6 months

• Being unemployed for at least 3 months

• Being diagnosed with Asthma

• Being diagnosed with C.O.P.D.

• Age < 35, for the group of Young Unemployed

• Age >35 years, for the groups of Asthma and C.O.P.D. patients

Exclusion Criteria:

• Diagnosed neurological, mental or psychiatric illness

• Drug-resistance epilepsy